At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 196 enrolled
Drug / intervention
Remote ischemic preconditioning (RIPC)procedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Neuroprotective Effect of Remote Ischemic Preconditioning on Ischemic Cerebral Vascular Disease
In Brief
A Phase 2 clinical trial evaluating Remote ischemic preconditioning (RIPC) for Cerebrovascular Disease. Completed, enrolled 196 participants across 1 site.
Detailed Summary
This study is a prospective, randomized, single-center trial, designed to observe the effect of remote limb ischemic preconditioning on ischemic cerebral vascular disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebrovascular Disease
CountriesChina
CollaboratorsNational Natural Science Foundation of China
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2008
First PostedMar 2011
Primary CompletionDec 2011
TodayJul 2026
First PostedMar 24, 2011
Enrollment StartJan 1, 2008
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 15.3 years ago
Interventions
Remote ischemic preconditioning (RIPC)procedure
The detail of RIPC included five cycles of bilateral upper limbs 5/5 min. of ischemia and reperfusion alternation. Limb ischemia was induced by inflating tourniquets to 200 mmHg. This process was placed on both arms every day.